The Effect of Quercetin on Plasma Interleukin-5, Blood Eosinophil Absolute, %FEV1, and Clinical Improvement of Asthma Alergy Patient

Hesti Nila Mayasari, Suradi Suradi, Ana Rima Setijadi


Backgrounds: Asthma is a chronic airway inflammation which is a manifestation of complex interactions between cells and moleculer mediators. The aims asthma management is to reach asthma in controlled state. Providing an additional therapy in these circumstances is necessary to control asthma. Quercetin as an adjunctive therapy in asthma therapy may improve clinical symptoms and lung function.
Methods: Experimental clinical trials of pretest of and postest design were conducted on 34 patient’s asthma at Dr. Moewardi Hospital Surakarta in October – December 2018. Subject of treatment group (n= 17) was given quercetin 500 mg per day within 28 days, the control group (n=17) received only standar therapy asthma. Decreased airway inflammation was assessed based on the percentage of blood eosinophil and IL-5. Clinical improvement was assessed by ACT score while lung function used FEV1.
Results: Quercetin decreased the inflammatory airways in patients with asthma evidenced by significant decrease in plasma IL-5 of treatment groups but no significant differences between treatment and control group, the mean decrease of blood eosinophil in the treatment group was significant. Querectin improved lung function with decrease FEV1 of treatment groups but no significant differences between treatment and control group and there was a clinical improvement with significant ACT score enhancement in the treatment group.
Conclusion: The administration of quercetin significantly reduced inflammation based on decreased levels of eosinophils. There are improvement of lung function and clinical symptoms after quercetin.


Quercetin, asthma, IL-5 plasma, blood eosinophil, FEV1, clinical improvement

Full Text:



Perhimpunan Dokter Paru Indonesia. Asma Pedoman Diagnosis Dan Penatalaksanaan Di Indonesia. Jakarta: Perhimpunan Dokter Paru Indonesia; 2004.

Grippi M. Milestones in the history of pulmonary medicine. In: Grippi MA, Elias JA, Fishman JA, Kotloff RM, Pack AI SR, editors. Fishman’s pulmonary diseases and disorders. 5th ed. New York: McGraw-Hill Education; 2015. p. 34–60.

Kementrian Kesehatan RI. Badan Penelitian dan Pengembangan Kesehatan. Riset kesehatan dasar (Riskedas) 2013. [cited 2018 May 26]. Available from:http://www.depkes.go,id/resources/download/general/Hasil%20Riskesdas%202013.pdf.

Subbaro P, Mandhane PJ, Sears M. Asthma: epidemiology, etiology and risk factors. Canadian Medical Association Journal. 2009;9:181-90.

Global Initiative for Asthma 2018. Global strategy for asthma management and prevention. Cape Town: GINA Executice Commite University of Cape Town Lung Institute.

Woodruff PG, Bhakta NR FJ. Asthma pathogenesis and phenotypes. In: Broaddus VC, Mason RJ, Ernst JD, King TE, Murray JF NJ, ed. Murray & nadel’s textbook of respiratory medicine. 6th editors. Philadelphia: Elsevier Saunders; 2010. p. 713-30.

Khan MA. Inflammation signals airway smooth muscle cell proliferation in asthma pathogenesis. Multidiscip Respir Med. 2013;8:1-5.

Weinberger ES, Cockrill B MJ. Asthma. In: Weinberger ES, Cockrill B MJ, ed. Principles of pulmonary medicine. 6th ed. Philadelphia: Elsevier; 2008. p. 73-90.

Lakhanpal P RD. Quercetin: a versatile flavonoid. Internet J Med Updat. 2007;2(2):22-37.

Bu T, Mi Y, Zeng W ZC. Protective effect of quercetin on cadmium-induced oxidative toxicity on germ cells in male mice. Anat Rec. 2011;526(268):520-26.

Barnes PJ. Immunology of asthma and chronic obstructive pulmonary disease. Nat Rev Immunol. 2008;8:183-92.

Barnes PJ. Pathophysiology of asthma. Eur Respir Mon. 2003;23:84-113.

Fortunato LR, Alves CDF, Teixeira MM RA. Quercetin: a flavonoid with the potential to treat asthma. Brazilian J Pharm Sci. 2012;48(4):12-19.

Ozgen S, Kilinc OK SZ. Antioxidant activity of quercetin: a mechanistic review. Turkish J Agric. 2016;4(12):1134-38.

Overman A, Chuang CC MM. Quercetin attenuates inflammation in human macrophages and adipocytes exposed to macrophage- conditioned media. Int J Obes. 2011;35(9):1165-7.

Muharrom A. Pengaruh Alfa Tokoferol Terhadap Kadar Interleukin-5 Plasma, Eosinofil Absolut Darah, %VEP1, Dan Perbaikan Klinis Pada Penderita Asma Alergi. Tesis. 2017.

Eagen TM, Gulsvik A, Eide GE, Bakke PS, 2004. The effect of educational level on the incidence of asthma and respiratory symptoms. Respir Med. 98(8):703-6 .

Holguin F, Comhair SAA, Hazen SL, Powers RW, Khatri SS, Bleecker ER, et al. An Association between L-Argininie/asymmetric dimethyl arginine balance, obesity, and the age of asthma onset phenotype. Am J Respir Crit Care Med. 2013.187:153-9.

De Nijs SB, Venekam LN, Bel EH. Adult onset asthma: is it really different?. Eur Respir Rev. 2013.22(147);44-52.



  • There are currently no refbacks.

Jurnal Respirologi Indonesia
pISSN: 0853-7704 - eISSN: 2620-3162
Address: Jalan Cipinang Bunder No. 19, Cipinang, Pulogadung, Jakarta Timur, DKI Jakarta 13240, Indonesia
Phone: +62-21-2247-4845

An official publication by
the Indonesian Society of Respirology (ISR)

Creative Commons License
Creative Commons Attribution-NonCommercial 4.0 International License